What Is Triglycerides? Normal vs Optimal Range Explained
Want to check YOUR levels? Upload labs freeFree, 10 seconds →
Normal vs Optimal Range
Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.
| Range Type | Low | High | Unit |
|---|---|---|---|
| Lab Normal | 0 | 150 | mg/dL |
| Optimal | 40 | 100 | mg/dL |
Why Optimal Matters
Triglycerides are the body's primary fat storage molecule, packaged by the liver when caloric intake exceeds immediate energy needs. Labs consider anything below 150 mg/dL normal, but that threshold was set to identify disease rather than optimize health. The CTD maps over 2,800 chemical interactions affecting lipid metabolism genes, reflecting the vast number of dietary, pharmaceutical, and hormonal factors that influence triglyceride levels. Triglycerides between 100 and 150 mg/dL—technically normal—already correlate with increased small dense LDL particles, early insulin resistance, and higher cardiovascular event rates compared to triglycerides below 80 mg/dL. The optimal range of 40–100 mg/dL reflects the metabolic zone where insulin sensitivity is high, LDL particles are predominantly large and buoyant (less atherogenic), and the liver is not overloaded with fat processing.
The triglyceride-to-HDL ratio has emerged as one of the most powerful metabolic screening tools available from a standard lipid panel. PubMed indexes over 48,000 publications on triglycerides and cardiovascular risk, with a growing body of evidence that a TG/HDL ratio below 2.0 (in mg/dL units) strongly predicts healthy insulin sensitivity and low cardiovascular risk, while a ratio above 3.5 identifies insulin resistance with sensitivity comparable to a formal glucose tolerance test. A patient with triglycerides of 140 mg/dL and HDL of 40 mg/dL (ratio 3.5) carries substantially more metabolic risk than someone with triglycerides of 60 mg/dL and HDL of 70 mg/dL (ratio 0.86)—yet both have normal triglycerides by lab standards. This ratio is the metabolic vital sign hiding in plain sight on every routine lipid panel.
Severely elevated triglycerides above 500 mg/dL pose the additional risk of acute pancreatitis, where fatty particles clog pancreatic capillaries and trigger organ inflammation. FAERS documents thousands of adverse event reports linking medications—particularly atypical antipsychotics, protease inhibitors, and high-dose estrogen—to severe hypertriglyceridemia exceeding 500 mg/dL. At levels above 1,000 mg/dL, pancreatitis risk becomes an emergency. For most patients, triglycerides respond dramatically to lifestyle changes: reducing refined carbohydrates and added sugars lowers triglycerides by 20 to 50 percent within weeks because the liver converts excess glucose and fructose directly into triglycerides. Alcohol reduction provides additional improvement because ethanol is preferentially metabolized into acetyl-CoA, which the liver packages into triglyceride-rich VLDL particles.
Want to see where YOUR levels fall?
Upload labs free — instant results →Symptoms When Low
Symptoms When High
What Affects This Marker
Medications That Lower It
FAQ
References
- [1]Comparative Toxicogenomics Database (CTD). Over 2,800 chemical interactions mapped for lipid metabolism genes. North Carolina State University, 2025.
- [2]PubMed. Over 48,000 indexed publications on triglycerides and cardiovascular risk. National Library of Medicine.
- [3]FDA Adverse Event Reporting System (FAERS). Adverse event reports linking medications to severe hypertriglyceridemia. FDA, 2025.
- [4]Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333. PMID: 21502576.
- [5]Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). New England Journal of Medicine. 2019;380(1):11-22. PMID: 30415628.
- [6]McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? American Journal of Cardiology. 2005;96(3):399-404. PMID: 16054467.
Check your medications
Check Free →